轻度和常见 2019 冠状病毒（COVID-19）患者的血常规检测。
Blood routine test in mild and common 2019 coronavirus (COVID-19) patients.
机构信息
Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei, China.
Department of Neurology, Hubei Aerospace Hospital, Xiaogan 432000, Hubei, China.
出版信息
Biosci Rep. 2020 Aug 28;40(8). doi: 10.1042/BSR20200817.
The new 2019 coronavirus disease (COVID-19), according to the World Health Organization (WHO), has been characterized as a pandemic. As more is being discovered about this virus, we aim to report findings of the complete blood count (CBC) of COVID-19 patients. This would serve in providing physicians with important knowledge on the changes that can be expected from the CBC of mild and normal COVID-19 patients. A total of 208 mild and common patients were admitted at the Dongnan Hospital located in the city of Xiaogan, Hubei, China. The CBCs of these patients, following a confirmed diagnosis of COVID-19, were retrospectively analyzed and a significant P<0.05 was found after a full statistical analysis was conducted using the Statistical Package for the Social Sciences (IBM SPSS). CBC analysis revealed changes in the levels of red blood cells (RBCs), hemoglobin (HGB), hematocrit (HCT), mean corpuscular volume (MCV), and C-reactive protein (CRP). Clinicians should expect similar findings when dealing with the new COVID-19.
世界卫生组织（WHO）将新型 2019 冠状病毒病（COVID-19）定性为大流行疾病。随着对该病毒的了解不断深入，我们旨在报告 COVID-19 患者的全血细胞计数（CBC）结果。这将为医生提供有关轻度和普通 COVID-19 患者的 CBC 预期变化的重要知识。共有 208 名轻度和普通患者入住位于中国湖北省孝感市的东南医院。对这些患者的 CBC 进行回顾性分析，并使用 IBM SPSS 统计软件包（IBM SPSS）进行全面统计分析后，发现具有统计学意义（P<0.05）。CBC 分析显示红细胞（RBC）、血红蛋白（HGB）、血细胞比容（HCT）、平均红细胞体积（MCV）和 C 反应蛋白（CRP）水平发生变化。临床医生在处理新的 COVID-19 时应预期会有类似的发现。
Zotero 插件